Additional European Equity News

AstraZeneca (AZN LN) - Saphnelo approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus. (AstraZeneca) 

Galp Energia (GALP PL) - Q1 (EUR): RCA EBITDA 943mln (exp. 872.1mln), Net Income 272mln (prev. 192mln Y/Y). (Galp Energia)